<div class="container">
    <div class="row">
        <div id="speaker-detail" class="col-lg-6 col-lg-offset-3">
            <div class="row">
                <button title="Close (Esc)" type="button" class="mfp-close">×</button>
                <div class="col-md-4 col-lg-4">
                    <img class="img-responsive" src="img/Industry_02.jpg" alt="" />
                    <br />
                </div>
                <div class="col-md-8 col-lg-8">
                    <h2>Frank Lee, 李文機 博士</h2>
                    <h3>Principal, FWL Consulting Services</h3>
                    <p>Dr. Lee is a pharmacokinetics and drug metabolism expert with 38 years of pharmaceutical industry experience. He is the co-founder of BRIM Biotechnology, Inc. and Chinese Entrepreneur Association, a non-profit organization.  He has been working as an individual consultant since his retirement in July 2012 from Millennium Pharmaceuticals, the Takeda Oncology Company as Vice President, NCDS in charge of DMPK. During his 38 years tenure in pharmaceutical industry Dr. Lee has made contributions to the development of several brand-name drugs such as Naprosyn®, Anaprox®, Ticlid®, Torado®, Avodart®, Flonase®, Imitrex®, Zofran®, Sustiva®, Velcade® Entyvio® and Ixazomib®.  Dr. Lee obtained his BS degree in chemistry from Chung Yuan Christian University in Taiwan in 1968, MS degree in organic chemistry from the California State University at Sacramento in 1974, and PhD degree in Pharmaceutical Chemistry from the University of California at San Francisco in 1987.
                    </p>
                </div>
            </div>
        </div>
    </div>
</div>
